Protein scaffold-based molecular probes for cancer molecular imaging

Amino Acids

Volumn 41, Issue 5, 2011, Pages 1037-1047

  Miao, Zheng ^a,b,c   Levi, Jelena ^a,c   Cheng, Zhen ^a,b,c,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY   (United States)

^d STANFORD CANCER INSTITUTE   (United States)

Author keywords

Cancer; Molecular imaging; Peptide; PET; Protein scaffolds

Indexed keywords

AGOUTI RELATED PROTEIN; AMYLASE INHIBITOR; ANKYRIN; APOLIPOPROTEIN D; BETA LACTAMASE TEM 1; CARCINOEMBRYONIC ANTIGEN; COPPER 64; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORINE 18; GALLIUM 68; INDIUM 111; IODINE 124; KNOTTIN; LIPOCALIN; MOLECULAR SCAFFOLD; SCAFFOLD PROTEIN; SERINE PROTEINASE INHIBITOR; TECHNETIUM 99M; TENDAMISTAT; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA; VITRONECTIN RECEPTOR; ZINOSTATIN;

BINDING AFFINITY; CANCER DIAGNOSIS; CANCER SCINTISCANNING; COLON CANCER; ISOTOPE LABELING; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; OPTICAL TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RADIOISOTOPE DIAGNOSIS; REVIEW; SCINTILLATION CAMERA; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; HUMANS; MOLECULAR IMAGING; MOLECULAR PROBES; NEOPLASMS; PROTEIN STRUCTURE, SECONDARY; PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84855215798     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-010-0503-9     Document Type: Review

References (63)

1. Ahlgren S, Orlova A, Rosik D, Sandström M, Sjöberg A, Baastrup B, Widmark O, Fant G, Feldwisch J, Tolmachev V (2008) Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules. Bioconjug Chem 19:235-243 (Pubitemid 351213855)
2. HER2:2395, with C-terminally engineered cysteine. J Nucl Med 50:781-789
3. Amstutz P, Binz HK, Parizek P, Stumpp MT, Kohl A, Grutter MG, Forrer P, Plückthun A (2005) Intracellular kinase inhibitors selected from combinatorial libraries of designed ankyrin repeat proteins. J Biol Chem 280:24715-24722 (Pubitemid 40941033)
4. Arbabi Ghahroudi M, Desmyter A, Wyns L, Hamers R, Muyldermans S (1997) Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett 414:521-526 (Pubitemid 27390659)
5. Austin J, Wang W, Puttamadappa S, Shekhtman A, Camarero JA (2009) Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I. ChemBioChem 10:2663-2670
6. Baum RP, Orlova A, Tolmachev V, Feldwisch J (2006) Receptor PET/CT and SPECT using an Affibody molecule for targeting and molecular imaging of HER2-positive cancer in animal xenografts and human breast cancer patients [abstract]. J Nucl Med 47(suppl):108P
7. Binz HK, Amstutz P, Kohl A, Stumpp MT, Briand C, Forrer P, Grutter MG, Plückthun A (2004) High-affinity binders selected from designed ankyrin repeat protein libraries. Nat Biotechnol 22:575-582 (Pubitemid 38590636)
8. Chen W, Zhu Z, Feng Y, Xiao X, Dimitrov DS (2008) Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain. J Mol Biol 382:779-789
9. 18F-labeled protein scaffold molecules. J Nucl Med 49:804-813 (Pubitemid 351717547)
10. 64Cu-labeled Affibody molecules for imaging of HER2 expressing tumors. Mol Imaging Biol (Epub ahead of print)
11. 99mTc-labeled nanobodies: a new type of targeted probes for imaging antigen expression. Curr Radiopharm 1:37-41
12. Di Carlo A, Mariano A, D'Alessandro V, Belli G, Romano G, Macchia V (2001) Evaluation of epidermal growth factor receptor, carcinoembryonic antigen and Lewis carbohydrate antigens in human colorectal and liver neoplasias. Oncol Rep 8:387-392 (Pubitemid 33758099)
13. 99mTc-labelled Affibody molecules with reduced renal uptake. Eur J Nucl Med Mol Imaging. 35:2245-2255
14. Engfeldt T, Renberg B, Brumer H, Nygren PA, Karlström AE (2005) Chemical synthesis of triple-labelled three-helix bundle binding proteins for specific fluorescent detection of unlabelled protein. ChemBioChem 6:1043-1050 (Pubitemid 40825345)
15. 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT. J Nucl Med 49:788-795 (Pubitemid 351717545)
16. Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2:683-693 (Pubitemid 37328919)
17. Getmanova EV, Chen Y, Bloom L, Gokemeijer J, Shamah S, Warikoo V, Wang J, Ling V, Sun L (2006) Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro. Chem. Biol. 13:549-556 (Pubitemid 43744513)
18. Gill DS, Damle NK (2006) Biopharmaceutical drug discovery using novel protein scaffolds. Curr Opin Biotechnol 17:653-658 (Pubitemid 44802987)
19. Goldman ER, Anderson GP, Liu JL, Delehanty JB, Sherwood LJ, Osborn LE, Cummins LB, Hayhurst A (2006) Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library. Anal Chem 78:8245-8255 (Pubitemid 44927600)
20. Harmsen MM, De Haard HJ (2007) Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol 77:13-22 (Pubitemid 47573319)
21. Heyd B, Pecorari F, Collinet B, Adjadj E, Desmadril M, Minard P (2003) In vitro evolution of the binding specificity of neocarzinostatin, an enediyne-binding chromoprotein. Biochemistry 42:5674-5683 (Pubitemid 36582858)
22. Hosse RJ, Rothe A, Power BE (2006) A new generation of protein display scaffolds for molecular recognition. Protein Sci 15:14-27 (Pubitemid 43004229)
23. 99mTc- labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression. Mol Imaging Biol 10:167-175
24. 3 integrin. J Nucl Med 51(2):251-258
25. Jonsson A, Dogan J, Herne N, Abrahmsén L, Nygren PA (2008) Engineering of a femtomolar affinity binding protein to human serum albumin. Protein Eng Des Sel 21:515-527 (Pubitemid 352019923)
26. Jonsson A, Wållberg H, Herne N, Ståhl S, Frejd FY (2009) Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro. Biotechnol Appl Biochem 54:93-103
27. Kimura RH, Cheng Z, Gambhir SS, Cochran JR (2009a) Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects. Cancer Res 69:2435-2442
28. Kimura RH, Levin AM, Cochran FV, Cochran JR (2009b) Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity. Proteins [Epub ahead of print]
29. Kimura RH, Miao Z, Cheng Z, Gambhir SS, Cochran JR (2009c) A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects. World Molecular Imaging Congress (abstract)
30. (HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography. Eur J Nucl Med Mol Imaging. 35:1008-1018
31. 18F-labeled affibody molecules. J Nucl Med 50:1131-1139
32. Ku J, Schultz PG (1995) Alternate protein frameworks for molecular recognition. Proc Natl Acad Sci 92:6552-6556
33. Ladner RC (1999) Polypeptides from phage display: a superior source of in vivo imaging agents. Q J Nucl Med 43:119-124 (Pubitemid 29318046)
34. Lamla T, Erdmann VA (2003) Searching sequence space for high affinity binding peptides using ribosome display. J Mol Biol 329:381-388 (Pubitemid 36561592)
35. Lamla T, Erdmann VA (2004) The Nano-tag, a streptavidin-binding peptide for the purification and detection of recombinant proteins. Protein Expr Purif 33:39-47 (Pubitemid 38069813)
36. Lee SB, Hassan M, Fisher R, Chertov O, Chernomordik V, Kramer- Marek G, Gandjbakhche A, Capala J (2008) Affibody molecules for in vivo characterization of HER2-positive tumors by nearinfrared imaging. Clin Cancer Res 14:3840-3849
37. Legendre D, Vucic B, Hougardy V, Girboux AL, Henrioul C, Van Haute J, Soumillion P, Fastrez J (2002) TEM-1 beta-lactamase as a scaffold for protein recognition and assay. Protein Sci 11:1506-1518 (Pubitemid 34547221)
38. Lehtio J, Teeri TT, Nygren PA (2000) a-Amylase inhibitors selected from a combinatorial library of a cellulose binding domain scaffold. Proteins 41:316-322
39. Li R, Hoess RH, Bennett JS, DeGrado WF (2003) Use of phage display to probe the evolution of binding specificity and affinity in integrins. Protein Eng 16:65-72 (Pubitemid 36407066)
40. Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545-580 (Pubitemid 36307540)
41. 18F for PET imaging of integrin expression. Bioconjug Chem 20(12):2342-2347
42. Miao Z, Ren G, Liu H, Jiang L, Wang YH, Gambhir SS, Cheng Z (2009b) Affibody based molecular probes for EGFR PET and optical imaging. World Molecular Imaging Congress Meeting (abstract)
43. Nygren PA, Skerra A (2004) Binding proteins from alternative scaffolds. J Immunol Methods 290:3-28 (Pubitemid 38922856)
44. Orlova A, Magnusson M, Eriksson TL, Nilsson M, Larsson B, Höidén- Guthenberg I, Widström C, Carlsson J, Tolmachev V, Ståhl S, Nilsson FY (2006a) Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res 66:4339-4448
45. Orlova A, Nilsson FY, Wikman M, Widström C, Ståhl S, Carlsson J, Tolmachev V (2006b) Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 Affibody for single-photon imaging of HER2 expression in tumors. J Nucl Med 47:512-519 (Pubitemid 46768494)
46. 124I-labeled affibody molecule and trastuzumab in a murine xenograft model. J Nucl Med 50:417-425
47. 68Ga for PET imaging of HER2 expression. J Nucl Med 50:1492-1499
48. Roberts BL, Markland W, Ley AC, Kent RB, White DW, Guterman SK, Ladner RC (1992) Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage. Proc Natl Acad Sci USA 89:2429-2433
49. Rothe A, Hosse RJ, Power BE (2006) In vitro display technologies reveal novel biopharmaceutics. FASEB J 20:1599-1610 (Pubitemid 44943797)
50. Schneider S, Buchert M, Georgiev O, Catimel B, Halford M, Stacker SA, Baechi T, Moelling K, Hovens CM (1999) Mutagenesis and selection of PDZ domains that bind new protein targets. Nat Biotechnol 17(2):170-175 (Pubitemid 29072542)
51. Signore A, Annovazzi A, Chianelli M, Corsetti F, Van de Wiele C, Watherhouse RN (2001) Peptide radiopharmaceuticals for diagnosis and therapy. Eur J Nucl Med 28:1556-1565
52. Silverman AP, Levin AM, Lahti JL, Cochran JR (2009) Engineered cystine-knot peptides that bind alpha(v)beta (3) integrin with antibody-like affinities. J Mol Biol 385(4):1064-1075
53. Thongyoo P, Bonomelli C, Leatherbarrow RJ, Tate EW (2009) Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold. J Med Chem 52:6197-6200
54. Tolmachev V, Nilsson FY, Widström C, Andersson K, Rosik D, Gedda L, Wennborg A, Orlova A (2006) 111In-benzyl-DTPAZHER2: 342, an Affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors. J Nucl Med 47:846-853 (Pubitemid 46772889)
55. Tolmachev V, Xu H, Wållberg H, Ahlgren S, Hjertman M, Sjöberg A, Sandström M, Abrahmsén L, Brechbiel MW, Orlova A (2008) Evaluation of a maleimido derivative of CHX-A00-DTPA for sitespecific labeling of Affibody molecules. Bioconjug Chem 9:1579-1587
56. Tolmachev V, Friedman M, Sandström M, Eriksson TL, Rosik D, Hodik M, Ståhl S, Frejd FY, Orlova A (2009) Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry. J Nucl Med 50:274-283
57. 99mTcmaEEE- Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors. Bioconjug Chem 18:1956-1964 (Pubitemid 350219996)
58. 99mTc to tumor-targeting Affibody molecules. Bioconjug Chem 18:549-558 (Pubitemid 46493528)
59. Uchiyama F, Tanaka Y, Minari Y, Tokui N (2005) Designing scaffolds of peptides for phage display libraries. J Biosci Bioeng 99:448-456 (Pubitemid 40874522)
60. Vogt M, Skerra A (2004) Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D. ChemBio- Chem 5:191-199 (Pubitemid 39268783)
61. Webster JM, Zhang R, Gambhir SS, Cheng Z, Syud FA (2009) Engineered two-helix small proteins for molecular recognition. Chembiochem 10:1293-1296
62. Wu AM, Senter PD (2005) Arming antibodies: prospects and challenges for immunoconjugates. Nat Biotechnol 23(9):1137-1146 (Pubitemid 41486395)
63. Xu L, Aha P, Gu K, Kuimelis RG, Kurz M, Lam T, Lim AC, Liu H, Lohse PA, Sun L, Weng S, Wagner RW, Lipovsek D (2002) Directed evolution of high affinity antibody mimics using mRNA display. Chem Biol 9:933-942 (Pubitemid 35240913)